NICM
ABMD

Neo Ivy Capital Management’s Abiomed Inc ABMD Stock Holding History

Neo Ivy Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-436
Closed -$63K – 638
2020
Q1 		$63K Buy
436
+31
+8% +$5.15K 0.1% 281
2019
Q4 		$69K Buy
+405
New +$75.1K 0.08% 199
2019
Q3 		– Sell
-733
Closed -$191K – 423
2019
Q2 		$191K Sell
733
-3,742
-84% -$993K 0.11% 208
2019
Q1 		$1.28M Buy
+4,475
New +$1.49M 0.73% 49

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Neo Ivy Capital Management's ABMD Position: Q2 2020 in Review

Neo Ivy Capital Management sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 436 shares — an estimated $63K sold.

Neo Ivy Capital Management first reported a position in ABMD in Q1 2019 and held it in 4 quarters. The position peaked at $1.28M in Q1 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Neo Ivy Capital Management reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Neo Ivy Capital Management sold 436 Abiomed Inc shares in Q2 2020, an estimated $63K.
  • Neo Ivy Capital Management first reported a position in Abiomed Inc in Q1 2019 and held it in 4 quarters.
  • Neo Ivy Capital Management's Abiomed Inc position peaked at $1.28M in Q1 2019.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.